ViiV Healthcare

Established in 2009 by GSK and Pfizer, with Shionogi joining as a shareholder in 2012, ViiV Healthcare was created to take an innovative approach to the challenges of HIV — and we do. We’re a diverse team of more than 1,300 scientists, innovators and believers who have been fighting HIV and supporting those affected by it since the epidemic began.

We are a global specialist HIV company — and the only pharmaceutical company solely focused on HIV — dedicated to delivering advances in treatment and care for people living with HIV and for those who could benefit from prevention. 

We partner with individuals and their communities to work together toward delivering and supporting more effective solutions in HIV care. We are part of the conversation: we listen; we hear; we learn. The voice of the HIV community informs everything we do to improve the lives of all people living with or affected by HIV, with an emphasis on those who most often get left behind.